CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 114 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $66,086,776 | +93.9% | 2,797,916 | +22.4% | 0.00% | +50.0% |
Q3 2023 | $34,083,425 | +34.8% | 2,285,944 | -1.0% | 0.00% | +100.0% |
Q2 2023 | $25,277,998 | +333.3% | 2,308,493 | +245.0% | 0.00% | – |
Q1 2023 | $5,833,994 | +37.5% | 669,036 | -1.1% | 0.00% | – |
Q4 2022 | $4,241,944 | +258.3% | 676,546 | +100.0% | 0.00% | – |
Q3 2022 | $1,184,000 | +10.9% | 338,273 | -6.6% | 0.00% | – |
Q2 2022 | $1,068,000 | -74.7% | 362,120 | -73.3% | 0.00% | – |
Q1 2022 | $4,224,000 | -6.3% | 1,358,050 | +1.8% | 0.00% | – |
Q4 2021 | $4,509,000 | -3.3% | 1,333,890 | +4.5% | 0.00% | – |
Q3 2021 | $4,661,000 | -21.2% | 1,276,967 | -5.9% | 0.00% | – |
Q2 2021 | $5,917,000 | +1.0% | 1,357,224 | +5.1% | 0.00% | – |
Q1 2021 | $5,860,000 | -43.5% | 1,290,846 | -28.6% | 0.00% | -100.0% |
Q4 2020 | $10,380,000 | -12.6% | 1,808,347 | +10.2% | 0.00% | 0.0% |
Q3 2020 | $11,877,000 | +140.6% | 1,640,514 | +16.0% | 0.00% | – |
Q2 2020 | $4,937,000 | +134.6% | 1,414,471 | -0.5% | 0.00% | – |
Q1 2020 | $2,104,000 | -23.9% | 1,421,566 | +0.8% | 0.00% | – |
Q4 2019 | $2,763,000 | -65.9% | 1,409,914 | -10.8% | 0.00% | -100.0% |
Q3 2019 | $8,097,000 | -29.6% | 1,581,453 | -1.5% | 0.00% | 0.0% |
Q2 2019 | $11,501,000 | -31.5% | 1,606,334 | +27.0% | 0.00% | 0.0% |
Q1 2019 | $16,796,000 | +66.4% | 1,264,755 | -1.4% | 0.00% | 0.0% |
Q4 2018 | $10,092,000 | -30.7% | 1,282,395 | -2.5% | 0.00% | 0.0% |
Q3 2018 | $14,571,000 | -17.8% | 1,315,230 | -0.5% | 0.00% | 0.0% |
Q2 2018 | $17,734,000 | +483.7% | 1,321,563 | +465.3% | 0.00% | – |
Q1 2018 | $3,038,000 | +642.8% | 233,790 | +425.1% | 0.00% | – |
Q4 2017 | $409,000 | +46.6% | 44,522 | +28.3% | 0.00% | – |
Q3 2017 | $279,000 | – | 34,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |